Company / EPS (Diluted)
Personalis, Inc. EPS (Diluted) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.37
FY2025
5-year range
-$2.25 / -$1.20
FY2021-FY2025
Trend
+39.1%
vs FY2024
Sector context
#131 of 159
Health Care
What the data says
Personalis, Inc.'s eps (diluted) of $-1.37 is lower than 82% of companies in the Health Care sector (FY2025). EPS (Diluted) returned to growth in FY2025 after 2 years of decline, reaching $-1.37.
Based on SEC 10-K filings.
-1.37 in FY2025.
Improved from $-1.49 to $-1.37 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 159This company -$1.37 Sector average $1.67
▼
-182.1% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 39.1% year-over-year.
- Ranks #131 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2022.
- Lowest eps (diluted) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.37 | +39.1% |
| FY2024 | -$2.25 | -51.0% |
| FY2023 | -$1.49 | -24.2% |
| FY2022 | -$1.20 | +13.7% |
| FY2021 | -$1.39 | +78.6% |
| FY2020 | -$6.49 | +16.6% |
| FY2019 | -$7.78 | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026